We are pleased to announce the appointment of our new Executive Team member: Dr. Riku Rautsola as Executive Chairman of the Board of Directors.
Riku brings over 40 years of proven track record in the biotech and CDMO industry across Europe, US and Asia. We welcome the experience and guidance he will bring to our organization.
We also extend our gratitude to Peter Prock, who will remain on our Board of Directors, for his invaluable contributions and unwavering dedication over the years. Peter has been instrumental in steering FAMAR through significant milestones, and we look forward to his continued insights and guidance.
This transition is reaffirming our commitment to excellence in serving our customers and communities.